25 XP   0   0   10

Amer Bio Medica
Buy, Hold or Sell?

Let's analyse Amer Bio Medica together

PenkeI guess you are interested in Amer Bio Medica. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Amer Bio Medica. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Amer Bio Medica

I send you an email if I find something interesting about Amer Bio Medica.

Quick analysis of Amer Bio Medica (30 sec.)










What can you expect buying and holding a share of Amer Bio Medica? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.05
Expected worth in 1 year
$-0.16
How sure are you?
20.0%

+ What do you gain per year?

Total Gains per Share
$-0.12
Return On Investment
-38,670.6%

For what price can you sell your share?

Current Price per Share
$0.00
Expected price per share
$0.0003 - $0.0003
How sure are you?
50%

1. Valuation of Amer Bio Medica (5 min.)




Live pricePrice per Share (EOD)

$0.00

Intrinsic Value Per Share

$-0.31 - $-0.12

Total Value Per Share

$-0.36 - $-0.17

2. Growth of Amer Bio Medica (5 min.)




Is Amer Bio Medica growing?

Current yearPrevious yearGrowGrow %
How rich?-$2.3m-$944k-$1.3m-59.6%

How much money is Amer Bio Medica making?

Current yearPrevious yearGrowGrow %
Making money-$1.4m-$463k-$947k-67.2%
Net Profit Margin-154.4%-20.9%--

How much money comes from the company's main activities?

3. Financial Health of Amer Bio Medica (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#132 / 145

Most Revenue
#131 / 145

Most Profit
#79 / 145

Most Efficient
#118 / 145

What can you expect buying and holding a share of Amer Bio Medica? (5 min.)

Welcome investor! Amer Bio Medica's management wants to use your money to grow the business. In return you get a share of Amer Bio Medica.

What can you expect buying and holding a share of Amer Bio Medica?

First you should know what it really means to hold a share of Amer Bio Medica. And how you can make/lose money.

Speculation

The Price per Share of Amer Bio Medica is $0.0003. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Amer Bio Medica.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Amer Bio Medica, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.05. Based on the TTM, the Book Value Change Per Share is $-0.03 per quarter. Based on the YOY, the Book Value Change Per Share is $0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Amer Bio Medica.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.03-9,771.6%-0.03-9,771.6%-0.01-3,208.7%-0.02-6,068.1%-0.01-4,767.3%
Usd Book Value Change Per Share-0.03-9,667.7%-0.03-9,667.7%0.012,162.2%-0.01-4,105.5%-0.01-2,566.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.03-9,667.7%-0.03-9,667.7%0.012,162.2%-0.01-4,105.5%-0.01-2,566.3%
Usd Price Per Share0.01-0.01-0.04-0.06-0.09-
Price to Earnings Ratio-0.34--0.34--4.16--4.10--8.36-
Price-to-Total Gains Ratio-0.34--0.34-6.17--3.43--90.78-
Price to Book Ratio-0.21--0.21--2.04--6.83--0.38-
Price-to-Total Gains Ratio-0.34--0.34-6.17--3.43--90.78-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0003
Number of shares3333333
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.03-0.01
Usd Total Gains Per Share-0.03-0.01
Gains per Quarter (3333333 shares)-96,676.60-41,054.64
Gains per Year (3333333 shares)-386,706.41-164,218.55
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-386706-3867160-164219-164229
20-773413-7734220-328437-328448
30-1160119-11601280-492656-492667
40-1546826-15468340-656874-656886
50-1933532-19335400-821093-821105
60-2320238-23202460-985311-985324
70-2706945-27069520-1149530-1149543
80-3093651-30936580-1313748-1313762
90-3480358-34803640-1477967-1477981
100-3867064-38670700-1642185-1642200

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%4.023.00.014.8%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%2.08.00.020.0%9.017.01.033.3%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%2.00.025.07.4%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%1.04.00.020.0%2.08.00.020.0%9.017.01.033.3%

Fundamentals of Amer Bio Medica

About Amer Bio Medica

American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 16 drugs. The company also offers a test for the detection of respiratory syncytial virus; OralStat, a drug test for the detection of drugs in oral fluids, as well as private labeled versions of OralStat. In addition, the company distributes other products for the detection of substances of abuse, as well as products to detect certain infectious diseases. Further, it provides strip contract manufacturing, assembly, and packaging services to unaffiliated diagnostic companies. The company serves rehabilitation/drug treatment, pain management, other clinical, government, and employment/workplace markets. It operates in the United States, North America, Europe, the Asia Pacific, and South America. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992. American Bio Medica Corporation was incorporated in 1986 and is based in Kinderhook, New York.

Fundamental data was last updated by Penke on 2024-04-11 08:28:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Amer Bio Medica.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Amer Bio Medica earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Amer Bio Medica to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -154.4% means that $-1.54 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Amer Bio Medica:

  • The MRQ is -154.4%. The company is making a huge loss. -2
  • The TTM is -154.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-154.4%TTM-154.4%0.0%
TTM-154.4%YOY-20.9%-133.6%
TTM-154.4%5Y-47.9%-106.5%
5Y-47.9%10Y-27.8%-20.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-154.4%-6.7%-147.7%
TTM-154.4%-6.7%-147.7%
YOY-20.9%0.3%-21.2%
5Y-47.9%-1.5%-46.4%
10Y-27.8%-3.4%-24.4%
1.1.2. Return on Assets

Shows how efficient Amer Bio Medica is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Amer Bio Medica to the Diagnostics & Research industry mean.
  • -111.1% Return on Assets means that Amer Bio Medica generated $-1.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Amer Bio Medica:

  • The MRQ is -111.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -111.1%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-111.1%TTM-111.1%0.0%
TTM-111.1%YOY-24.6%-86.5%
TTM-111.1%5Y-50.3%-60.8%
5Y-50.3%10Y-31.7%-18.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-111.1%-1.3%-109.8%
TTM-111.1%-1.3%-109.8%
YOY-24.6%-0.9%-23.7%
5Y-50.3%-0.5%-49.8%
10Y-31.7%-0.9%-30.8%
1.1.3. Return on Equity

Shows how efficient Amer Bio Medica is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Amer Bio Medica to the Diagnostics & Research industry mean.
  • 0.0% Return on Equity means Amer Bio Medica generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Amer Bio Medica:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-26.5%+26.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--0.5%+0.5%
TTM--0.0%
YOY-0.3%-0.3%
5Y--1.4%+1.4%
10Y-26.5%-2.3%-24.2%

1.2. Operating Efficiency of Amer Bio Medica.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Amer Bio Medica is operating .

  • Measures how much profit Amer Bio Medica makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Amer Bio Medica to the Diagnostics & Research industry mean.
  • An Operating Margin of -136.0% means the company generated $-1.36  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Amer Bio Medica:

  • The MRQ is -136.0%. The company is operating very inefficient. -2
  • The TTM is -136.0%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-136.0%TTM-136.0%0.0%
TTM-136.0%YOY-53.2%-82.9%
TTM-136.0%5Y-48.0%-88.0%
5Y-48.0%10Y-26.9%-21.1%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-136.0%-6.2%-129.8%
TTM-136.0%0.5%-136.5%
YOY-53.2%4.0%-57.2%
5Y-48.0%3.7%-51.7%
10Y-26.9%-1.3%-25.6%
1.2.2. Operating Ratio

Measures how efficient Amer Bio Medica is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 2.46 means that the operating costs are $2.46 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Amer Bio Medica:

  • The MRQ is 2.459. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.459. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.459TTM2.4590.000
TTM2.459YOY1.532+0.927
TTM2.4595Y1.500+0.959
5Y1.50010Y1.280+0.220
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4591.280+1.179
TTM2.4591.304+1.155
YOY1.5321.236+0.296
5Y1.5001.242+0.258
10Y1.2801.205+0.075

1.3. Liquidity of Amer Bio Medica.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Amer Bio Medica is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 0.21 means the company has $0.21 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Amer Bio Medica:

  • The MRQ is 0.213. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.213. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.213TTM0.2130.000
TTM0.213YOY0.475-0.261
TTM0.2135Y0.577-0.363
5Y0.57710Y0.945-0.368
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2132.111-1.898
TTM0.2132.298-2.085
YOY0.4752.599-2.124
5Y0.5773.012-2.435
10Y0.9453.081-2.136
1.3.2. Quick Ratio

Measures if Amer Bio Medica is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Amer Bio Medica to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.09 means the company can pay off $0.09 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Amer Bio Medica:

  • The MRQ is 0.088. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.088. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.088TTM0.0880.000
TTM0.088YOY0.297-0.208
TTM0.0885Y0.233-0.145
5Y0.23310Y0.324-0.091
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0881.204-1.116
TTM0.0881.319-1.231
YOY0.2971.602-1.305
5Y0.2331.943-1.710
10Y0.3242.203-1.879

1.4. Solvency of Amer Bio Medica.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Amer Bio Medica assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Amer Bio Medica to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 2.84 means that Amer Bio Medica assets are financed with 284.3% credit (debt) and the remaining percentage (100% - 284.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Amer Bio Medica:

  • The MRQ is 2.843. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.843. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ2.843TTM2.8430.000
TTM2.843YOY1.501+1.342
TTM2.8435Y1.687+1.156
5Y1.68710Y1.216+0.472
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8430.429+2.414
TTM2.8430.407+2.436
YOY1.5010.394+1.107
5Y1.6870.450+1.237
10Y1.2160.450+0.766
1.4.2. Debt to Equity Ratio

Measures if Amer Bio Medica is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Amer Bio Medica to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Amer Bio Medica:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y1.480-1.480
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.606-0.606
TTM-0.571-0.571
YOY-0.631-0.631
5Y-0.658-0.658
10Y1.4800.735+0.745

2. Market Valuation of Amer Bio Medica

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Amer Bio Medica generates.

  • Above 15 is considered overpriced but always compare Amer Bio Medica to the Diagnostics & Research industry mean.
  • A PE ratio of -0.34 means the investor is paying $-0.34 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Amer Bio Medica:

  • The EOD is -0.010. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.341. Based on the earnings, the company is expensive. -2
  • The TTM is -0.341. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.010MRQ-0.341+0.331
MRQ-0.341TTM-0.3410.000
TTM-0.341YOY-4.155+3.814
TTM-0.3415Y-4.103+3.762
5Y-4.10310Y-8.360+4.257
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.010-0.235+0.225
MRQ-0.341-0.395+0.054
TTM-0.341-0.284-0.057
YOY-4.1550.002-4.157
5Y-4.1034.834-8.937
10Y-8.3605.200-13.560
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Amer Bio Medica:

  • The EOD is -0.019. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.626. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.626. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.019MRQ-0.626+0.607
MRQ-0.626TTM-0.6260.000
TTM-0.626YOY-2.859+2.232
TTM-0.6265Y5.610-6.237
5Y5.61010Y14.499-8.889
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.019-0.277+0.258
MRQ-0.626-0.441-0.185
TTM-0.626-1.389+0.763
YOY-2.859-2.030-0.829
5Y5.610-1.446+7.056
10Y14.499-1.971+16.470
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Amer Bio Medica is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of -0.21 means the investor is paying $-0.21 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Amer Bio Medica:

  • The EOD is -0.006. Based on the equity, the company is expensive. -2
  • The MRQ is -0.206. Based on the equity, the company is expensive. -2
  • The TTM is -0.206. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.006MRQ-0.206+0.199
MRQ-0.206TTM-0.2060.000
TTM-0.206YOY-2.038+1.832
TTM-0.2065Y-6.830+6.624
5Y-6.83010Y-0.383-6.447
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-0.0061.897-1.903
MRQ-0.2062.222-2.428
TTM-0.2062.168-2.374
YOY-2.0383.041-5.079
5Y-6.8303.477-10.307
10Y-0.3834.125-4.508
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Amer Bio Medica compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.029-0.0290%0.006-547%-0.012-58%-0.008-73%
Book Value Per Share---0.049-0.0490%-0.020-60%-0.023-53%-0.001-98%
Current Ratio--0.2130.2130%0.475-55%0.577-63%0.945-77%
Debt To Asset Ratio--2.8432.8430%1.501+89%1.687+69%1.216+134%
Debt To Equity Ratio----0%-0%-0%1.480-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.029-0.0290%-0.010-67%-0.018-38%-0.014-51%
Free Cash Flow Per Share---0.016-0.0160%-0.014-12%-0.009-45%-0.003-79%
Free Cash Flow To Equity Per Share---0.002-0.0020%0.000-576%0.000-100%0.000-92%
Gross Profit Margin--1.0971.0970%1.657-34%1.515-28%2.485-56%
Intrinsic Value_10Y_max---0.118--------
Intrinsic Value_10Y_min---0.310--------
Intrinsic Value_1Y_max---0.005--------
Intrinsic Value_1Y_min---0.018--------
Intrinsic Value_3Y_max---0.021--------
Intrinsic Value_3Y_min---0.066--------
Intrinsic Value_5Y_max---0.042--------
Intrinsic Value_5Y_min---0.126--------
Market Cap14429.550-3233%480985.000480985.0000%1923940.000-75%3066760.360-84%4400050.780-89%
Net Profit Margin---1.544-1.5440%-0.209-86%-0.479-69%-0.278-82%
Operating Margin---1.360-1.3600%-0.532-61%-0.480-65%-0.269-80%
Operating Ratio--2.4592.4590%1.532+61%1.500+64%1.280+92%
Pb Ratio-0.006+97%-0.206-0.2060%-2.038+891%-6.830+3221%-0.383+86%
Pe Ratio-0.010+97%-0.341-0.3410%-4.155+1118%-4.103+1103%-8.360+2351%
Price Per Share0.000-3233%0.0100.0100%0.040-75%0.064-84%0.091-89%
Price To Free Cash Flow Ratio-0.019+97%-0.626-0.6260%-2.859+356%5.610-111%14.499-104%
Price To Total Gains Ratio-0.010+97%-0.345-0.3450%6.166-106%-3.426+894%-90.777+26228%
Quick Ratio--0.0880.0880%0.297-70%0.233-62%0.324-73%
Return On Assets---1.111-1.1110%-0.246-78%-0.503-55%-0.317-71%
Return On Equity----0%-0%-0%-0.2650%
Total Gains Per Share---0.029-0.0290%0.006-547%-0.012-58%-0.008-73%
Usd Book Value---2339000.000-2339000.0000%-944000.000-60%-1095000.000-53%-55800.000-98%
Usd Book Value Change Per Share---0.029-0.0290%0.006-547%-0.012-58%-0.008-73%
Usd Book Value Per Share---0.049-0.0490%-0.020-60%-0.023-53%-0.001-98%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.029-0.0290%-0.010-67%-0.018-38%-0.014-51%
Usd Free Cash Flow---768000.000-768000.0000%-673000.000-12%-422400.000-45%-157700.000-79%
Usd Free Cash Flow Per Share---0.016-0.0160%-0.014-12%-0.009-45%-0.003-79%
Usd Free Cash Flow To Equity Per Share---0.002-0.0020%0.000-576%0.000-100%0.000-92%
Usd Market Cap14429.550-3233%480985.000480985.0000%1923940.000-75%3066760.360-84%4400050.780-89%
Usd Price Per Share0.000-3233%0.0100.0100%0.040-75%0.064-84%0.091-89%
Usd Profit---1410000.000-1410000.0000%-463000.000-67%-875600.000-38%-687900.000-51%
Usd Revenue--913000.000913000.0000%2218000.000-59%2961000.000-69%4782400.000-81%
Usd Total Gains Per Share---0.029-0.0290%0.006-547%-0.012-58%-0.008-73%
 EOD+2 -6MRQTTM+0 -0YOY+1 -315Y+3 -2910Y+4 -29

3.2. Fundamental Score

Let's check the fundamental score of Amer Bio Medica based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.010
Price to Book Ratio (EOD)Between0-1-0.006
Net Profit Margin (MRQ)Greater than0-1.544
Operating Margin (MRQ)Greater than0-1.360
Quick Ratio (MRQ)Greater than10.088
Current Ratio (MRQ)Greater than10.213
Debt to Asset Ratio (MRQ)Less than12.843
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.111
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of Amer Bio Medica based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5086.026
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2018-12-312019-12-312020-12-312021-12-312022-12-31
Net Invested Capital  1,382-710672-12454851599-708-109
Gross Profit  1,288-1041,184541,238-690548-741-193



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,269
Total Liabilities3,608
Total Stockholder Equity-2,339
 As reported
Total Liabilities 3,608
Total Stockholder Equity+ -2,339
Total Assets = 1,269

Assets

Total Assets1,269
Total Current Assets769
Long-term Assets500
Total Current Assets
Cash And Cash Equivalents 34
Net Receivables 284
Inventory 379
Other Current Assets 72
Total Current Assets  (as reported)769
Total Current Assets  (calculated)769
+/-0
Long-term Assets
Property Plant Equipment 479
Other Assets 21
Long-term Assets  (as reported)500
Long-term Assets  (calculated)500
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities3,602
Long-term Liabilities6
Total Stockholder Equity-2,339
Total Current Liabilities
Short-term Debt 2,234
Short Long Term Debt 2,230
Accounts payable 760
Other Current Liabilities 608
Total Current Liabilities  (as reported)3,602
Total Current Liabilities  (calculated)5,832
+/- 2,230
Long-term Liabilities
Capital Lease Obligations 10
Long-term Liabilities  (as reported)6
Long-term Liabilities  (calculated)10
+/- 4
Total Stockholder Equity
Common Stock481
Retained Earnings -25,223
Other Stockholders Equity 22,403
Total Stockholder Equity (as reported)-2,339
Total Stockholder Equity (calculated)-2,339
+/-0
Other
Capital Stock481
Cash and Short Term Investments 34
Common Stock Shares Outstanding 48,018
Liabilities and Stockholders Equity 1,269
Net Debt 2,206
Net Invested Capital -109
Net Tangible Assets -2,339
Net Working Capital -2,833
Property Plant and Equipment Gross 3,989
Short Long Term Debt Total 2,240



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-31
> Total Assets 
4,107
4,107
5,400
4,435
5,038
5,086
5,648
6,778
8,375
7,938
9,017
9,150
9,136
7,040
6,015
5,636
4,779
4,966
4,078
3,797
3,371
2,891
2,475
2,078
1,926
1,883
1,269
1,2691,8831,9262,0782,4752,8913,3713,7974,0784,9664,7795,6366,0157,0409,1369,1509,0177,9388,3756,7785,6485,0865,0384,4355,4004,1074,107
   > Total Current Assets 
3,929
3,929
5,000
3,802
3,809
3,518
4,184
5,330
6,511
6,369
6,978
6,876
7,011
5,267
4,505
4,276
3,520
3,739
3,016
2,616
2,386
1,954
1,613
1,227
1,180
1,340
769
7691,3401,1801,2271,6131,9542,3862,6163,0163,7393,5204,2764,5055,2677,0116,8766,9786,3696,5115,3304,1843,5183,8093,8025,0003,9293,929
       Cash And Cash Equivalents 
1,763
1,763
3,200
131
1,207
288
231
942
995
446
641
336
201
35
37
93
89
646
352
158
156
36
113
4
98
115
34
3411598411336156158352646899337352013366414469959422312881,2071313,2001,7631,763
       Short-term Investments 
1,053
1,053
719
719
74
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000747197191,0531,053
       Net Receivables 
440
440
700
1,021
1,150
1,053
1,105
1,261
1,108
1,370
1,313
1,365
1,161
816
743
883
810
875
814
672
556
348
452
370
407
723
284
2847234073704523485566728148758108837438161,1611,3651,3131,3701,1081,2611,1051,0531,1501,021700440440
       Inventory 
669
669
1,000
1,834
1,332
2,087
2,795
3,049
4,338
4,444
4,859
4,994
5,552
4,315
3,604
3,239
2,571
2,071
1,722
1,746
1,582
1,473
1,019
810
536
443
379
3794435368101,0191,4731,5821,7461,7222,0712,5713,2393,6044,3155,5524,9944,8594,4444,3383,0492,7952,0871,3321,8341,000669669
       Other Current Assets 
4
4
100
97
46
90
53
78
70
109
165
181
97
101
121
61
50
147
128
40
92
97
29
43
139
59
72
7259139432997924012814750611211019718116510970785390469710044
   > Long-term Assets 
178
178
400
633
1,229
1,568
1,464
1,448
1,864
1,569
2,039
2,274
2,125
1,773
1,510
1,360
1,259
1,227
1,062
1,181
985
937
862
854
746
543
500
5005437468548629379851,1811,0621,2271,2591,3601,5101,7732,1252,2742,0391,5691,8641,4481,4641,5681,229633400178178
       Property Plant Equipment 
111
111
100
351
388
1,455
1,457
1,441
1,859
1,562
1,982
2,267
1,961
1,624
1,409
1,304
1,192
1,090
983
910
824
792
718
717
617
522
479
4795226177177187928249109831,0901,1921,3041,4091,6241,9612,2671,9821,5621,8591,4411,4571,455388351100111111
       Intangible Assets 
67
67
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24
43
65
67
93
109
123
116
108
0
0
001081161231099367654324000000000000006767
       Other Assets 
0
0
0
449
182
113
7
7
5
7
57
7
164
149
101
56
43
94
14
93
68
36
21
-3
21
21
21
212121-321366893149443561011491647577577113182449000
> Total Liabilities 
380
380
500
1,462
1,827
2,733
2,328
2,016
2,537
2,385
2,980
4,054
4,878
3,662
3,358
3,266
3,415
3,628
3,108
2,836
2,346
2,268
2,621
2,868
3,182
2,827
3,608
3,6082,8273,1822,8682,6212,2682,3462,8363,1083,6283,4153,2663,3583,6624,8784,0542,9802,3852,5372,0162,3282,7331,8271,462500380380
   > Total Current Liabilities 
380
380
500
1,415
1,793
2,026
1,605
1,298
1,854
1,733
2,122
2,859
3,881
1,776
1,604
2,391
3,146
3,357
2,703
1,729
1,593
1,477
1,825
1,687
2,021
2,824
3,602
3,6022,8242,0211,6871,8251,4771,5931,7292,7033,3573,1462,3911,6041,7763,8812,8592,1221,7331,8541,2981,6052,0261,7931,415500380380
       Short-term Debt 
0
0
136
136
138
43
184
33
77
46
193
844
1,539
367
623
1,269
1,725
2,213
1,837
852
714
533
739
388
717
1,578
2,234
2,2341,5787173887395337148521,8372,2131,7251,2696233671,5398441934677331844313813613600
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
858
75
714
533
739
354
684
1,543
2,230
2,2301,54368435473953371475858000000000000000000
       Accounts payable 
0
500
500
1,149
1,655
1,064
908
737
1,358
1,510
1,091
1,403
1,568
678
432
631
1,043
621
414
379
309
385
359
652
577
682
760
7606825776523593853093794146211,0436314326781,5681,4031,0911,5101,3587379081,0641,6551,1495005000
       Other Current Liabilities 
380
380
130
130
928
357
513
375
243
177
329
392
774
721
539
481
12
75
39
91
93
12
702
637
560
512
608
608512560637702129391397512481539721774392329177243375513357928130130380380
   > Long-term Liabilities 
0
0
500
47
34
707
723
718
683
652
858
1,195
997
1,886
1,754
875
269
271
405
1,107
753
791
796
1,181
1,161
3
6
631,1611,1817967917531,1074052712698751,7541,8869971,195858652683718723707344750000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
213
945
753
772
789
1,108
1,120
0
0
001,1201,108789772753945213000000000000000000
       Other Liabilities 
0
0
0
0
0
0
50
67
54
60
100
88
237
156
150
143
145
147
68
38
0
19
0
0
0
0
0
0000019038681471451431501562378810060546750000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
79
47
15
0
0
0
0
0
000001547790000000000000000000
> Total Stockholder Equity
3,727
3,727
4,900
2,973
3,211
2,353
3,320
4,762
5,838
5,553
6,037
5,096
4,258
3,378
2,657
2,370
1,364
1,338
970
961
1,025
623
-146
-790
-1,256
-944
-2,339
-2,339-944-1,256-790-1466231,0259619701,3381,3642,3702,6573,3784,2585,0966,0375,5535,8384,7623,3202,3533,2112,9734,9003,7273,727
   Common Stock
134
134
149
149
180
207
206
207
213
214
217
217
217
217
217
217
218
229
236
260
288
298
323
327
377
476
481
481476377327323298288260236229218217217217217217217214213207206207180149149134134
   Retained Earnings -25,223-23,813-23,350-22,554-21,873-20,845-20,300-19,955-19,622-19,132-18,344-17,233-16,888-16,138-15,238-14,388-13,398-13,514-13,138-13,404-14,435-15,154-11,643-9,424-7,300-2,907-2,907
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,356
20,656
21,037
21,170
21,404
21,437
21,717
0
0
0021,71721,43721,40421,17021,03720,65620,356000000000000000000
   Treasury Stock00000000000000000000-239-2300000
   Other Stockholders Equity 
6,500
6,500
12,300
12,326
14,897
17,742
17,973
18,551
19,610
20,078
20,819
19,267
21,577
21,888
22,200
19,386
19,490
20,241
20,356
20,656
21,037
21,170
21,404
21,437
21,717
22,393
22,403
22,40322,39321,71721,43721,40421,17021,03720,65620,35620,24119,49019,38622,20021,88821,57719,26720,81920,07819,61018,55117,97317,74214,89712,32612,3006,5006,500



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue913
Cost of Revenue-1,106
Gross Profit-193-193
 
Operating Income (+$)
Gross Profit-193
Operating Expense-1,139
Operating Income-1,242-1,332
 
Operating Expense (+$)
Research Development85
Selling General Administrative917
Selling And Marketing Expenses137
Operating Expense1,1391,139
 
Net Interest Income (+$)
Interest Income3
Interest Expense-194
Other Finance Cost-0
Net Interest Income-191
 
Pretax Income (+$)
Operating Income-1,242
Net Interest Income-191
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,408-1,076
EBIT - interestExpense = -1,436
-1,408
-1,216
Interest Expense194
Earnings Before Interest and Taxes (EBIT)-1,242-1,214
Earnings Before Interest and Taxes (EBITDA)-1,163
 
After tax Income (+$)
Income Before Tax-1,408
Tax Provision-2
Net Income From Continuing Ops-1,410-1,410
Net Income-1,410
Net Income Applicable To Common Shares-1,410
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,245
Total Other Income/Expenses Net-166191
 

Technical Analysis of Amer Bio Medica
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Amer Bio Medica. The general trend of Amer Bio Medica is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Amer Bio Medica's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Amer Bio Medica.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.0003 < 0.0003 < 0.0003.

The bearish price targets are: 0.0003 > 0.0003 > 0.0003.

Tweet this
Amer Bio Medica Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Amer Bio Medica. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Amer Bio Medica Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Amer Bio Medica. The current macd is 0.000013.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Amer Bio Medica price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Amer Bio Medica. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Amer Bio Medica price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Amer Bio Medica Daily Moving Average Convergence/Divergence (MACD) ChartAmer Bio Medica Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Amer Bio Medica. The current adx is 71.25.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Amer Bio Medica shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Amer Bio Medica Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Amer Bio Medica. The current sar is 0.00013325.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Amer Bio Medica Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Amer Bio Medica. The current rsi is 86.03. The current phase is Overbought in neutral market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in neutral market:
Amer Bio Medica Daily Relative Strength Index (RSI) ChartAmer Bio Medica Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Amer Bio Medica. The current phase is Oversold in neutral market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Amer Bio Medica price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Amer Bio Medica Daily Stochastic Oscillator ChartAmer Bio Medica Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Amer Bio Medica. The current cci is 0.

Amer Bio Medica Daily Commodity Channel Index (CCI) ChartAmer Bio Medica Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Amer Bio Medica. The current cmo is 95.42.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Amer Bio Medica Daily Chande Momentum Oscillator (CMO) ChartAmer Bio Medica Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Amer Bio Medica. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Amer Bio Medica Daily Williams %R ChartAmer Bio Medica Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Amer Bio Medica.

Amer Bio Medica Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Amer Bio Medica. The current atr is 0.00000.

Amer Bio Medica Daily Average True Range (ATR) ChartAmer Bio Medica Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Amer Bio Medica. The current obv is 379,514.

Amer Bio Medica Daily On-Balance Volume (OBV) ChartAmer Bio Medica Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Amer Bio Medica. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Amer Bio Medica Daily Money Flow Index (MFI) ChartAmer Bio Medica Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Amer Bio Medica.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-18MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-23BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-04MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Amer Bio Medica Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Amer Bio Medica based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5086.026
Ma 20Greater thanMa 500.000
Ma 50Greater thanMa 1000.000
Ma 100Greater thanMa 2000.000
OpenGreater thanClose0.000
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Amer Bio Medica with someone you think should read this too:
  • Are you bullish or bearish on Amer Bio Medica? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Amer Bio Medica? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Amer Bio Medica

I send you an email if I find something interesting about Amer Bio Medica.


Comments

How you think about this?

Leave a comment

Stay informed about Amer Bio Medica.

Receive notifications about Amer Bio Medica in your mailbox!